
Sophia S. Chen
Examiner (ID: 4164, Phone: (571)272-2133 , Office: P/2852 )
| Most Active Art Unit | 2852 |
| Art Unit(s) | 2809, 2105, 2852 |
| Total Applications | 3623 |
| Issued Applications | 3447 |
| Pending Applications | 91 |
| Abandoned Applications | 111 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8779607
[patent_doc_number] => 20130101582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-25
[patent_title] => 'Tiki1 and Tiki2, Wnt Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/715443
[patent_app_country] => US
[patent_app_date] => 2012-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 23958
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13715443
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/715443 | Tiki1 and Tiki2, Wnt Inhibitors | Dec 13, 2012 | Abandoned |
Array
(
[id] => 9174964
[patent_doc_number] => 20130316949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'Compositions and Methods for Minimally-Invasive Systemic Delivery of Proteins Including TGF-Beta Superfamily Members'
[patent_app_type] => utility
[patent_app_number] => 13/707717
[patent_app_country] => US
[patent_app_date] => 2012-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13066
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13707717
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/707717 | Compositions and Methods for Minimally-Invasive Systemic Delivery of Proteins Including TGF-Beta Superfamily Members | Dec 6, 2012 | Abandoned |
Array
(
[id] => 8768024
[patent_doc_number] => 20130096061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-18
[patent_title] => 'METHOD OF TREATING SKELETAL DYSPLASIAS USING VESSEL DILATOR'
[patent_app_type] => utility
[patent_app_number] => 13/693372
[patent_app_country] => US
[patent_app_date] => 2012-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7448
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13693372
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/693372 | METHOD OF TREATING SKELETAL DYSPLASIAS USING VESSEL DILATOR | Dec 3, 2012 | Abandoned |
Array
(
[id] => 9122044
[patent_doc_number] => 20130288966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-31
[patent_title] => 'Peripheral Administration of Proteins Including TGF-beta Superfamily Members for Treatment of Systemic Disorders and Disease'
[patent_app_type] => utility
[patent_app_number] => 13/680381
[patent_app_country] => US
[patent_app_date] => 2012-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14439
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 41
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13680381
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/680381 | Peripheral Administration of Proteins Including TGF-beta Superfamily Members for Treatment of Systemic Disorders and Disease | Nov 18, 2012 | Abandoned |
Array
(
[id] => 8815142
[patent_doc_number] => 20130116187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-09
[patent_title] => 'ARTIFICIAL CARTILAGE AND ITS PRODUCTION METHOD'
[patent_app_type] => utility
[patent_app_number] => 13/670738
[patent_app_country] => US
[patent_app_date] => 2012-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4991
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13670738
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/670738 | ARTIFICIAL CARTILAGE AND ITS PRODUCTION METHOD | Nov 6, 2012 | Abandoned |
Array
(
[id] => 8950080
[patent_doc_number] => 20130195860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'Antibody targeting through a modular recognition domain'
[patent_app_type] => utility
[patent_app_number] => 13/694155
[patent_app_country] => US
[patent_app_date] => 2012-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12877
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13694155
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/694155 | Antibody targeting through a modular recognition domain | Oct 31, 2012 | Abandoned |
Array
(
[id] => 9183432
[patent_doc_number] => 08623364
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-07
[patent_title] => 'Antigenic GM-CSF peptides and antibodies to GM-CSF'
[patent_app_type] => utility
[patent_app_number] => 13/659165
[patent_app_country] => US
[patent_app_date] => 2012-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 16
[patent_no_of_words] => 27511
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13659165
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/659165 | Antigenic GM-CSF peptides and antibodies to GM-CSF | Oct 23, 2012 | Issued |
Array
(
[id] => 10926231
[patent_doc_number] => 20140329252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-06
[patent_title] => 'METHODS AND KITS FOR DIAGNOSING AND/OR PROGNOSING OSTEOARTHRITIS'
[patent_app_type] => utility
[patent_app_number] => 14/351398
[patent_app_country] => US
[patent_app_date] => 2012-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 19837
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14351398
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/351398 | METHODS AND KITS FOR DIAGNOSING AND/OR PROGNOSING OSTEOARTHRITIS | Oct 14, 2012 | Abandoned |
Array
(
[id] => 9936880
[patent_doc_number] => 08986685
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-24
[patent_title] => 'Compositions and methods for increasing bone mineralization'
[patent_app_type] => utility
[patent_app_number] => 13/644728
[patent_app_country] => US
[patent_app_date] => 2012-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 27729
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13644728
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/644728 | Compositions and methods for increasing bone mineralization | Oct 3, 2012 | Issued |
Array
(
[id] => 9383438
[patent_doc_number] => 20140086919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'METHODS AND COMPOSITONS FOR REGULATING IRON HOMEOSTASIS BY MODULATION OF BMP-6'
[patent_app_type] => utility
[patent_app_number] => 13/625049
[patent_app_country] => US
[patent_app_date] => 2012-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 18701
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13625049
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/625049 | METHODS AND COMPOSITONS FOR REGULATING IRON HOMEOSTASIS BY MODULATION OF BMP-6 | Sep 23, 2012 | Abandoned |
Array
(
[id] => 10354937
[patent_doc_number] => 20150239942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'USE OF PEDF-DERIVED POLYPEPTIDES FOR TREATING OSTEOARTHRITIS'
[patent_app_type] => utility
[patent_app_number] => 14/429693
[patent_app_country] => US
[patent_app_date] => 2012-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8166
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14429693
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/429693 | Use of PEDF-derived polypeptides for treating osteoarthritis | Sep 19, 2012 | Issued |
Array
(
[id] => 12037659
[patent_doc_number] => 09815878
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-14
[patent_title] => 'Use of PEDF-derived polypeptides for preventing and/or ameliorating skin aging'
[patent_app_type] => utility
[patent_app_number] => 14/429681
[patent_app_country] => US
[patent_app_date] => 2012-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 10357
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14429681
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/429681 | Use of PEDF-derived polypeptides for preventing and/or ameliorating skin aging | Sep 18, 2012 | Issued |
Array
(
[id] => 8606134
[patent_doc_number] => 20130011446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-10
[patent_title] => 'CERAMIC COMPOSITION FOR FILLING BONE DEFECTS'
[patent_app_type] => utility
[patent_app_number] => 13/614369
[patent_app_country] => US
[patent_app_date] => 2012-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4597
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13614369
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/614369 | CERAMIC COMPOSITION FOR FILLING BONE DEFECTS | Sep 12, 2012 | Abandoned |
Array
(
[id] => 9016320
[patent_doc_number] => 20130231284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-05
[patent_title] => 'METHODS OF TREATING CARTILAGE DEFECTS'
[patent_app_type] => utility
[patent_app_number] => 13/612251
[patent_app_country] => US
[patent_app_date] => 2012-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 18873
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13612251
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/612251 | METHODS OF TREATING CARTILAGE DEFECTS | Sep 11, 2012 | Abandoned |
Array
(
[id] => 9254433
[patent_doc_number] => 08617844
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-31
[patent_title] => 'Use of cytokine receptors as biomarkers and therapeutic targets in human cancer'
[patent_app_type] => utility
[patent_app_number] => 13/595436
[patent_app_country] => US
[patent_app_date] => 2012-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5009
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13595436
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/595436 | Use of cytokine receptors as biomarkers and therapeutic targets in human cancer | Aug 26, 2012 | Issued |
Array
(
[id] => 10654718
[patent_doc_number] => 20160000862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-07
[patent_title] => 'USE OF PEDF-DERIVED POLYPEPTIDES FOR PROMOTING MUSCLE OR TENDON REGENERATION OR ARTERIOGENESIS'
[patent_app_type] => utility
[patent_app_number] => 14/420581
[patent_app_country] => US
[patent_app_date] => 2012-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14581
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14420581
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/420581 | Use of PEDF-derived polypeptides for promoting muscle or tendon regeneration or arteriogenesis | Aug 8, 2012 | Issued |
Array
(
[id] => 8950059
[patent_doc_number] => 20130195838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'Methods of Treating Cancer Using Growth Factor Retargeted Endopeptidases'
[patent_app_type] => utility
[patent_app_number] => 13/571283
[patent_app_country] => US
[patent_app_date] => 2012-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 82611
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13571283
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/571283 | Methods of Treating Cancer Using Growth Factor Retargeted Endopeptidases | Aug 8, 2012 | Abandoned |
Array
(
[id] => 15395879
[patent_doc_number] => 10538584
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-21
[patent_title] => Methods for treating bone gap defects
[patent_app_type] => utility
[patent_app_number] => 14/233137
[patent_app_country] => US
[patent_app_date] => 2012-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 6
[patent_no_of_words] => 16478
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14233137
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/233137 | Methods for treating bone gap defects | Aug 1, 2012 | Issued |
Array
(
[id] => 8495390
[patent_doc_number] => 20120294798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-22
[patent_title] => 'METHODS OF TREATING CANCER USING IL-21'
[patent_app_type] => utility
[patent_app_number] => 13/535832
[patent_app_country] => US
[patent_app_date] => 2012-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49624
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13535832
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/535832 | METHODS OF TREATING CANCER USING IL-21 | Jun 27, 2012 | Abandoned |
Array
(
[id] => 9263144
[patent_doc_number] => 20130345073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'USE OF ALPHA-2-MACROGLOBULIN FOR DETERMINING OSTEONECROSIS DISEASE STATUS AND FOR SCREENING THERAPEUTIC AGENTS FOR PREVENTING OR TREATING OSTEONECROSIS'
[patent_app_type] => utility
[patent_app_number] => 13/530342
[patent_app_country] => US
[patent_app_date] => 2012-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 26877
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13530342
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/530342 | USE OF ALPHA-2-MACROGLOBULIN FOR DETERMINING OSTEONECROSIS DISEASE STATUS AND FOR SCREENING THERAPEUTIC AGENTS FOR PREVENTING OR TREATING OSTEONECROSIS | Jun 21, 2012 | Abandoned |